Scholarly Index
Nanxin Li
Vertex Pharmaceuticals (United States); 22,042 total citations; 206 total publications; best world rank #177
Vertex Pharmaceuticals (United States)
22,042Total citations
206Total publications
44H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 978 | US 406 | 92.60 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 460 | US 222 | 90.99 |
| Hemophilia Treatment and Research | 2021-2025 | 177 | US 48 | 91.34 |
| Iron Metabolism and Disorders | 2021-2025 | 476 | US 170 | 87.52 |